U.S. federal trademark · Serial No. 85437196 · Reg. No. 4297107
Software for processing medical data, namely, diagnosis and treatment of abnormal blood glucose to provide real time review of patient outcomes and remotely view the level of care and other medical information which is helpful in protocol verification and refinements of a treatment to normalize metabolism
Medical diagnostic testing and treatment services for humans with metabolic disorders such as diabetes, Alzheimer's, Parkinson's Disease, and diseases of reduced cellular energy all of which respond by normalization of metabolic integrity
Educational services, namely, providing classes to medical personnel and the general public about use of medical devices for dosing insulin to address metabolic deficiencies in order to achieve normalized cellular energy (ATP)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.